Contact Information for CYDY Board Members

I have written to all CYDY board members to object to, and ask the basis for, the 11,000,000 share "performance bonus" that was announced yesterday.

I also objected to the amount of Pourhassan's $1.5M compensation package.

Although some may choose to defend Pourhassan's compensation, it is difficult, in my opinion, to justify the 6,000,000 share performance bonus awarded to him in addition to his compensation package, even if the FDA grants BTD for Leronlimab for breast cancer, as seeking BTD is part of a CEO's job duties.

I further objected to the board awarding themselves performance bonuses as I view this as a conflict of interest akin to the fox guarding the hen house.

Should anyone wish to contact CYDY board members, the contact information I have for them is as follows:

Jordan G. Naydenov
Milara, Inc.
49 Maple Street
Milford, MA. 01757
jordan@milarasmt.com
508-533-5322

David F. Welch, Ph.D.
Infinera Corporation
140 Caspian Court
Sunnyvale, CA. 94089

Scott A. Kelly, M.D.
C/O Resurgens Orthopaedics Spine Center
6635 Lake Drive
Morrow, GA. 30260
404-229-6606
770-968-1323

Alan P. Timmins
Financial Affairs, MSC 171
500 N. Willamette Blvd.
Portland, OR. 92703
timmins@up.edu

LM